Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol

Tiziano, FD; Lomastro, R; Abiusi, E; Pasanisi, MB; Di Pietro, L; Fiori, S; Baranello, G; ... Morandi, L; + view all Tiziano, FD; Lomastro, R; Abiusi, E; Pasanisi, MB; Di Pietro, L; Fiori, S; Baranello, G; Angelini, C; Sorarù, G; Gaiani, A; Mongini, T; Vercelli, L; Mercuri, E; Vasco, G; Pane, M; Vita, G; Vita, G; Messina, S; Petillo, R; Passamano, L; Politano, L; Campanella, A; Mantegazza, R; Morandi, L; - view fewer (2018) Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol. Journal of Medical Genetics 10.1136/jmedgenet-2018-105482 . (In press). Green open access

https://ift.tt/2ShSTly